Turn Therapeutics Inc.
TTRX
$5.25
$0.000.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.98M | 1.97M | 1.48M | 1.48M | 1.49M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.24M | 2.24M | 1.76M | 1.68M | 1.60M |
| Operating Income | -3.24M | -2.24M | -1.76M | -1.68M | -1.60M |
| Income Before Tax | -3.01M | -2.13M | -1.73M | -1.65M | -1.58M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.01 | -2.13 | -1.73 | -1.65 | -1.58 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.01M | -2.13M | -1.73M | -1.65M | -1.58M |
| EBIT | -3.24M | -2.24M | -1.76M | -1.68M | -1.60M |
| EBITDA | -3.19M | -2.19M | -1.71M | -1.64M | -1.56M |
| EPS Basic | -0.11 | -0.08 | -0.06 | -0.06 | -0.06 |
| Normalized Basic EPS | -0.07 | -0.05 | -0.04 | -0.04 | -0.04 |
| EPS Diluted | -0.11 | -0.08 | -0.06 | -0.06 | -0.06 |
| Normalized Diluted EPS | -0.07 | -0.05 | -0.04 | -0.04 | -0.04 |
| Average Basic Shares Outstanding | 109.08M | 108.09M | 107.39M | 106.69M | 105.98M |
| Average Diluted Shares Outstanding | 109.08M | 108.09M | 107.39M | 106.69M | 105.98M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |